Evaluation of a New Thermostable Formulation of FLOLAN in Japanese Subjects

NCT02705807 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Disease

Interventions

DRUG: FLOLAN injection with currently marketed diluent
DRUG: FLOLAN injection with reformulated diluent

Sponsor

GlaxoSmithKline